Showing results (891-900 of 999) with videos related to

Sort By:
Pageof 100
Circulation|October 28, 2021
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENALArjun Majithia, Deepak L Bhatt, Allon N Friedman, et al.
Journal of Clinical Lipidology|May 24, 2011
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial HypercholesterolemiaAnne C Goldberg, Paul N Hopkins, Peter P Toth, et al.
JAMA Cardiology|April 10, 2024
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1Seyedmohammad Saadatagah, Mohammadreza Naderian, Mesbah Uddin, et al.
Molecular Psychiatry|February 3, 2023
Plasma proteins related to inflammatory diet predict future cognitive impairmentMichael R Duggan, Lauren Butler, Zhongsheng Peng, et al.
American Heart Journal|February 16, 2018
Association of lipoprotein-associated phospholipase A<sub>2</sub> and risk of incident atrial fibrillation: Findings from 3 cohortsParveen K Garg, Traci M Bartz, Faye L Norby, et al.
Journal of the American College of Cardiology|April 28, 2022
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial InfarctionPrakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, et al.
JAMA|April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical TrialSteven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.
Journal of Clinical Lipidology|May 24, 2011
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial HypercholesterolemiaAnne C Goldberg, Paul N Hopkins, Peter P Toth, et al.
Clinical Cardiology|August 21, 2018
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trialStephen J Nicholls, A Michael Lincoff, Dianna Bash, et al.
Circulation. Cardiovascular Imaging|May 25, 2010
Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studiesMenno Vergeer, Rong Zhou, Michiel L Bots, et al.
Pageof 100